Implications for practice: Weekly paclitaxel schedules are extensively used in breast cancer. Patients may develop symptomatic and objective neuropathy early in the treatment course, with these individuals requiring closer monitoring. Furthermore, neuropathy is a long-term sequela which may impact quality...
Weekly paclitaxel wins in metastatic breast cancerThe article focuses on a study which found that weekly administration of paclitaxel is more effective than administration every 3 weeks in treating patients with metastatic breast cancer. It notes that time to progression and overall survival duration ...
Weekly adjuvant paclitaxel improves survival after standard chemotherapy in breast cancerdoi:10.1038/ncponc1171NoneNature Clinical Practice OncologyWeekly adjuvant paclitaxel improves survival after standard chemotherapy in breast cancer. Nature Clinical Practice Oncology 5 , 498-498 /...
Weekly Paclitaxel in Women Age 65 and Above with Metastatic Breast Cancer* We evaluated therapy with weekly paclitaxel 80mg/m 2 in metastatic breast cancer patients age ≥65. There was a low incidence of serious toxicities, with ... EA Perez,CL Vogel,DH Irwin,... - 《Breast Cancer ...
A randomized phase II study of Xeloda (TM) (capecitabine) vs paclitaxel in breast cancer patients failing previous anthracycline therapy Capecitabine, an oral fluoropyrimidine carbamate, was designed to generate 5-fluorouracil preferentially at the tumour site. This randomised, phase II trial evaluated ...
CONCLUSION: Weekly paclitaxel is modestly effective and safe in docetaxel-resistant metastatic breast cancer patients. However, weekly paclitaxel should not be recommended for primary resistance patients with docetaxel.doi:10.1007/s10549-004-2184-0
Molecular predictors of efficacy of adjuvant paclitaxel weekly in early breast cancer 翻译结果5复制译文编辑译文朗读译文返回顶部 Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer 相关内容 a也不会觉得冷 Also cannot think coldly[translate] ...
Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer. Breast Cancer Research and Treatment 166: 241-247, No. 1, Nov 2017. Available from: URL: http://doi.org/10.1007/s10549-017-4362-x - USA Article CAS PubMed Google Scholar Download references ...
Conclusions Biweekly paclitaxel may be suitable for patients receiving paclitaxel for palliative therapy, as tolerance was similar to that with the weekly schedule, but with the advantage of increased convenience. 展开 关键词:Paclitaxel Breast cancer Biweekly ...
We studied 13 women aged 29-62 years for response to weekly administration of paclitaxel for metastatic breast cancer. Paclitaxel was administered by 1-hour intravenous infusion at a dose of 60-80 mg/m2 once a week. Administration was continued for 3 weeks with a 1-week rest for at least...